Literature DB >> 11195007

Intracranial hemorrhage in children with immune thrombocytopenic purpura

H Iyori1, F Bessho, H Ookawa, S Konishi, A Shirahata, S Miyazaki, K Fujisawa, J Akatsuka.   

Abstract

We sent questionnaires to hospitals in Japan in order to study the incidence and conditions of intracranial hemorrhage (ICH) in children with immune thrombocytopenic purpura (ITP). From 1980 to 1995, 11 cases of ICH were reported in eight patients with ITP at 35 institutions. One patient had ICH four times, but only one patient died of the condition. From 1990 through 1995, ICH occurred in four (0.52%) of 772 patients with ITP. None of the patients died. The platelet count when ICH occurred was 5.2 +/- 3.7 x 10(9)/l (mean +/- SD) (n = 11). Four of the eight patients (1980-1995) had received active treatment [e.g. intravenous immunoglobulin G (i.v. IgG)] immediately before ICH occurred. In seven cases (1980-1995), possible causes of ICH, including menstruation (n = 2) and viral infections (n = 3), were identified. Systemic lupus erythematosus (SLE) later developed in three patients. Although the incidence of ICH in children with ITP has not decreased compared with the rates in earlier studies, the mortality rate has decreased markedly. Our results suggest that menstruation, infection, and risk factors for progression to SLE may help to predict ICH in children with ITP. Large-scale prospective trials are needed to identify risk factors for ICH.

Entities:  

Mesh:

Year:  2000        PMID: 11195007     DOI: 10.1007/s002770000219

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  6 in total

Review 1.  Pediatric ITP: is it different from adult ITP?

Authors:  Jenny M Despotovic; Amanda B Grimes
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Clinical practice: immune thrombocytopenia in paediatrics.

Authors:  Veerle Labarque; Chris Van Geet
Journal:  Eur J Pediatr       Date:  2014-01-05       Impact factor: 3.183

3.  Rituximab leads to long remissions in patients with chronic immune thrombocytopenia.

Authors:  Khalid Al-Habsi; Murtadha Al-Khabori; Muhanna Al-Muslahi; Anil Pathare; Khalil Al-Farsi; Mohammed Al-Huneini; Sulayma Al-Lamki; Salam Al-Kindi
Journal:  Oman Med J       Date:  2015-03

Review 4.  Treatment of immune thrombocytopenic purpura in children : current concepts.

Authors:  Aziza T Shad; Corina E Gonzalez; S G Sandler
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.

Authors:  Bethan Psaila; Aleksandra Petrovic; Lemke K Page; Jill Menell; Matthew Schonholz; James B Bussel
Journal:  Blood       Date:  2009-09-18       Impact factor: 22.113

6.  Intracranial hemorrhage after high-dose methylprednisolone in a child with acute immune thrombocytopenic purpura.

Authors:  Katja M J Heitink-Pollé; Dirk Jan Pot; Marjolein Engelkes; Marrie C A Bruin
Journal:  Ann Hematol       Date:  2011-02-18       Impact factor: 3.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.